The role of non-clinicians in a goal setting model for the management of allergic rhinitis in community pharmacy settings

Patient Education and Counseling

Volumn 85, Issue 2, 2011, Pages

  Smith, Lorraine ^a   Nguyen, Tony ^b   Seeto, Celina ^c   Saini, Bandana ^a   Brown, Lin ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c Merck Sharp and Dohme (Australia)   (Australia)

Author keywords

Allergic rhinitis; Community pharmacy; Goal setting; Self management

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISEASE SEVERITY; EMPOWERMENT; EVIDENCE BASED MEDICINE; FEMALE; HAY FEVER; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT AUTONOMY; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACIST; PHARMACIST ATTITUDE; PHARMACY; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SELF CARE; SELF CONCEPT; SELF REPORT; THEMATIC ANALYSIS; TIME MANAGEMENT; WORKLOAD;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; GOALS; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHARMACIES; PILOT PROJECTS; QUESTIONNAIRES; REGRESSION ANALYSIS; RHINITIS, ALLERGIC, SEASONAL; SELF CARE;

EID: 80053951900     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2010.10.003     Document Type: Article

References (35)

1. Australian Health Ministers' Conference. Blueprint for chronic disease surveillance; 2005 [cited April 24, 2008]. Available from: http://www.nphp.gov.au/publications/blueprint_disease_surveillance.pdf.
2. Whelan J. WHO calls for countries to shift from acute to chronic care. Br Med J 2002, 324.
3. Lorig K., Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med 2003, 26:1-7.
4. Battersby M. Health reform through coordinated care: SA HealthPlus. Br Med J 2005, 330:662-665. the SA HealthPlus Team.
5. Bousquet J., van Cauwenberge P., Khaltaev N. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergy 2004, 59:373-387. Members of the Workshops.
6. Craig T., Ferguson B., Krouse J. Sleep impairment in allergic rhinitis, rhinosinusitis and nasal polyposis. Am J Otolaryngol 2008, 29:209-217.
7. Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma (ARIA), in collaboration with the World Health Organisation. J Allergy Clin Immun 2001, 108(Suppl):S147-S334. the WHO Panel.
8. Bousquet J., Neukirch F., Bousquet P., Gehano P., Klossek J., Le Gal M., et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immun 2006, 117:158-162.
9. Dixon A. Rhinosinusitis and asthma: the missing link. Curr Opin Pulmon Med 2009, 15:19-24.
10. Crystal-Peters J., Neslusan C., Crown W., Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immun 2002, 109:57-62.
11. Cook M., Douglass J., Mallon D. The economic impact of allergic disease in Australia: not to be sneezed at. Aust Soc Clin Immunol Allergy (ASCIA) 2007, 1-111.
12. Walls R.S., Heddle R.J., Tang M.L.K., Basger B.J., Solley G.O., Yeo G.T. Optimising the management of allergic rhinitis: an Australian perspective. MJA practice essentials - allergies 2007, 48-53. Australasian Medical Publishing Company Pty Ltd., Pyrmont, NSW. S.A. Kemp, R.J. Mullins, J.M. Weiner (Eds.).
13. Marple B., Fornadley J., Patel A., Fineman S., Fromer L., Krouse J., et al. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otol Head Neck Surg 2007, 136(Suppl):S107-S124.
14. Armour C., Bosnic-Anticevich S., Brilliant M., Burton D., Emmerton L., Krass I., et al. Pharmacy Asthma Care Program (PACP). Thorax 2007, 62:496-502.
15. Smith L., Bosnic-Anticevich S., Mitchell B., Saini B., Krass I., Armour C. Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting. Soc Sci Med 2007, 64:1501-1511.
16. Saini B., Krass I., Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care mode. Ann Pharmaco 2004, 38:1954-1960.
17. Williams G., Freedman Z. E.D. Supporting autonomy to motivate patients with diabetes for glucose control. Diabetes Care 1998, 21:1644-1651.
18. Petrie K., Broadbent E., Meechan G. Self-regulatory interventions for improving the management of chronic illness. The self-regulation of health and illness behaviour 2003, 257-278. Routledge, New York. H. Leventhal (Ed.).
19. Bandura A. The primacy of self-regulation in health promotion. Appl Psychol: Inter Rev 2005, 54:245-254.
20. Bodenheimer T., Handley M. Goal-setting for behavior change in primary care: an exploration and status report. Patient Educ Coun 2009, 76:174-180.
21. Szeinbach S., Williams P., Kucukarslan S., Elhefni H. Influence of patient care provider on patient health outcomes in allergic rhinitis. Ann Allergy Asthma Immunol 2005, 95:167-174.
22. Backer V., Nepper-Christensen S., Nolte H. Quality of care in patients with asthma and rhinitis treated by respiratory specialists and primary care physicians: a 3-year randomized and prospective follow-up study. Ann Allergy Asthma Immunol 2006, 97:490-496.
23. Gregory C., Cifaldi M., Tanner L. Targeted intervention programs: creating a customized practice model to improve the treatment of allergic rhinitis in a managed care population. Am J Manag Care 1999, 5:485-496.
24. O'Connor J., Seeto C., Saini B., Bosnic-Anticevich S., Krass I., Armour C., et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Patient Educ Coun 2008, 70:111-117.
25. Scheier M., Carver C. Self-regulatory processes and responses to health threats: effects of optimism on well-being. Social psychological foundations of health and illness 2003, 395-429. Blackwell Publishing, Victoria. J. Suls, K. Wallston (Eds.).
26. Martin R., Rothrock N., Leventhal H., Leventhal E. Common sense models of illness: implications for symptom perception and health-related behaviors. Social psychological foundations of health and illness 2003, 199-226. Blackwell Publishing, Victoria. J. Suls, K. Wallston (Eds.).
27. Juniper E., Thompson A., Ferrie P., Roberts J. Development and validation of the mini rhinoconjunctivitis quality of life questionnaire. Clin Exper Allergy 2000, 30:132-140.
28. Spector S., Nicklas R., Chapman J., Bernstein L., Berger W., Blessing-Moore J., et al. Symptom severity of allergic rhinitis. Part 1. Ann Allergy Asthma Immunol 2003, 91:105-114.
29. Lorig K., Sobel D., Ritter D., Laurent K., Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract 2001, 4:256-262.
30. Dolder C., Lacro J., Warren K., Golshan S., Perkins D., Jeste D. Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence. J Clin Psychopharmacol 2004, 24:404-409.
31. Miles M., Huberman A. Qualitative data analysis 1994, Sage publications, Thousand Oaks. 2nd ed.
32. Hayden M., Womack C. Caring for patients with allergic rhinitis. J Am Acad Nurse Pract 2007, 19:290-298.
33. Deci E., Ryan R. The "what" and "why" of goal pursuits: human needs and the self-determination of behavior. Psychol Inq 2000, 11:227-268.
34. DeWalt D., Davis T., Wallace A., Seligman H., Bryant-Shilliday B., Arnold C., et al. Goal setting in diabetes self-management: taking the baby steps to success. Patient Educ Coun 2009, 77:218-223.
35. Sabate E. Adherence to long term therapies: evidence for action. Geneva: World Health Organisation; 2003. Available from: http://www.who.int/chp/knowledge/publications/adherencerep.pdf.